KVUE stock price: Kenvue plummets as Trump announcement expected to tie Tylenol to autism, tout leucovorin

fastcompany.com/91408354/kvue-kenvue-stock-price-falls-trump-expected-to-tie-tylenol-to-autism-announcement-leucovorin

Shares of Kenvue Inc. (KVUE), the parent company of Tylenol, are down around 6% in midday trading on Monday on news the Trump administration is expected to link the over-the-counter pain relief medicine to autism.
According to MSNBC, there is growing alarm in the medical community ahead…

This story appeared on fastcompany.com, 2025-09-22 17:30:00.
The Entire Business World on a Single Page. Free to Use →